Impact of pretest on posttest knowledge scores with a Solomon Four research design

Cancer Nursing

Volumn 30, Issue 5, 2007, Pages

  Weinrich, Sally P ^a   Seger, Rachelle ^b   Curtsinger, Tim ^b   Pumphrey, Gwen ^b   NeSmith, Elizabeth G ^a   Weinrich, Martin C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

African Americans; Benefits and limitations; Decision aid; Experimental design; Knowledge; Low income; Medically underserved; Prostate cancer screening; Solomon Four

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PRETEST POSTTEST CONTROL GROUP DESIGN; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL ANALYSIS;

ADULT; AFRICAN AMERICANS; AGED; DIGITAL RECTAL EXAMINATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; KENTUCKY; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NURSING RESEARCH; PAMPHLETS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; POVERTY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RESEARCH DESIGN;

EID: 34548686854     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NCC.0000290820.22195.5b     Document Type: Article

References (50)

1. Weinrich SP. The debate about prostate cancer screening: what nurses need to know. Semin Oncol Nurs. 2001;17(2):78-84.
2. American Cancer Society. Cancer Facts and Figures 2005. Atlanta, Ga: American Cancer Society; 2005.
3. U.S. Preventative Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137(11):915-916.
4. Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. [comment]. J Urol. 1994;152(5 Pt 2):1905.
5. Wilt TJ, Partin MR. Prostate cancer intervention - involving the patient in early detection and treatment. Postgrad Med. 2003;114(4):43.
6. Taylor KL, Shelby R, Kerner J, Redd W, Lynch J. Impact of undergoing prostate carcinoma screening on prostate carcinoma-related knowledge and distress. Cancer. 2002;95(5):1037.
7. Campbell DT, Stanley JC. Experimental and Quasi-experimental designs for research. Chicago, Ill: Chicago Rand McNally College Publishing Company; 1980.
8. Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins HB. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet. Eff Clin Pract. 2001;4(3):112.
9. Dignan M, Michielutte R, Blinson K, et al. Effectiveness of health education to increase screening for cervical cancer among eastern-band Cherokee Indian women in North Carolina. J Natl Cancer Inst. 1996;88(22):1670.
10. Swenson-Britt E, Carrougher G, Martin BW, Brackley M. Project Hope: changing care delivery for the substance abuse patient. Clin Nurse Spec. 2000;14(2):92.
11. Erickson CK, Wilcox RE, Miller GW, Littlefield JH, Lawson KA. Effectiveness of addiction science presentations to treatment professionals, using a modified Solomon study design. J Drug Educ. 2003;33(2):197.
12. Kvalem IL, Sundet JM, Rivo KI, Eilertsen DA, Bakketeig LS. The effect of sex education on adolescents' use of condoms: applying the Solomon four-group design. [see comment]. Health Educ Q. 1996;23(1):34.
13. Linde CD, Stuart AD. A cognitive-relaxation-visualization intervention for anxiety in women with breast cancer. Health SA Gesondheid Interdiscip Res J. 2002;7:68-78.
14. Mullins LC, Merriam S. The effects of a short-term death training program on nursing home nursing staff. Death Educ. 1984;7(4):353.
15. Aschen SR. Assertion training therapy in psychiatric milieus. Arch Psychiatr Nurs. 1997;11(1):46.
16. Rimer B, Levy MH, Keintz MK, Fox L, Engstrom PF, MacElwee N. Enhancing cancer pain control regimens through patient education. Patient Educ Couns. 1987;10(3):267.
17. Lusk SL, Hong OS, Ronis DL, Eakin BL, Kerr MJ, Early MR. Effectiveness of an intervention to increase construction workers' use of hearing protection. Hum Factors. 1999;41(3):487.
18. Michel Y, Haight BK. Using the Solomon Four Design. Nurs Res. 1996;45(6):367.
19. Jefferson County KY Sample by zip code and demographics [computer program]. Fairfield, CT: Survey Sampling International; 2000.
20. Weinrich SP, Seger R, Miller BL, et al. Knowledge of the limitations associated with prostate cancer screening among low-income men. Cancer Nurs. 2004;27(6):442-453.
21. Weinrich MC, Weinrich SP, Weissbecker I, Mayberry-Brent K, Seger R. Recruitment incentives to reduce disparities among medically underserved men. Am J Health Stud. 2004;19(1):45-53.
22. Bandura A. Social Learning Theory. Englewood Cliffs, NJ: NJ Prentice Hall; 1977.
23. Weinrich SP, Boyd MD, Weinrich M, Greene F, Reynolds WA Jr, Metlin C. Increasing prostate cancer screening in African American men with peer-educator and client-navigator interventions. J Cancer Educ. 1998;13(4):213-219.
24. Arkin EB. Cancer risk communication - what we know. J Natl Cancer Inst Monogr. 1999;25:182-185.
25. Chan EC, Sulmasy DP. What should men know about prostate-specific antigen screening before giving informed consent? [comment]. Am J Med. 1998;105(4):266.
26. Myers RE, Chodak GW, Wolf TA, et al. Adherence by African American men to prostate cancer education and early detection. [comment]. Cancer. 1999;86(1):88.
27. Weinrich SP, Boyd M, Powe BD, Stromborg MF, S. Olsen. Tools adaptation for socioeconomically disadvantaged populations. In: Stromberg MF, Olsen S, eds. Instruments for Clinical Nursing Research. Boston, Mass: Oncology Nursing Society; 1997:20-29.
28. Weinrich SP. The high risk of low literacy. Reflections. 1999;4:22.
29. Guidry JJ, Fagan P, Walker V. Cultural sensitivity and readability of breast and prostate printed cancer education materials targeting African Americans. J Natl Med Assoc. 1998;90(3):165.
30. Boyd M, Graham B, Gliet C, Whitman N. Health Teaching in Nursing Practice: A Professional Model. Norwalk, Conn: CT Appleton-Lange; 1997.
31. Nunnally JC, Bernstein IH. Psychometric Theory. New York: McGraw-Hill; 1994.
32. Weinrich SP, Faison-Smith L, Hudson-Priest J, Royal C, Powell I. Stability of self-reported family history of prostate cancer among African American men. J Nurs Meas. 2002;10(1):39-46.
33. Weinrich SP, Weinrich MC, Boyd MD, Atkinson C. The impact of prostate cancer knowledge on cancer screening. Oncol Nurs Forum. 1998;25(3):527.
34. Myers RE, Wolf TA, McKee L, et al. Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia. Cancer. 1996;78(3):471.
35. Barber KR, Shaw R, Folts M, et al. Differences between African American and Caucasian men participating in a community-based prostate cancer screening program. J Community Health. 1998;23(6):441.
36. Conlisk EA, Lengerich EJ, Demark-Wahnefried W, Schildkraut JM, Aldrich TE. Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina. Urology. 1999;53(6):1194.
37. Demark-Wahnefried W, Strigo T, Catoe K, et al. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology. 1995;46(3):346.
38. Federman DG, Goyal S, Kamina A, Peduzzi P, Concato J. Informed consent for PSA screening: does it happen? Eff Clin Pract. 1999;2(4):152.
39. Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. [comment]. BMJ. 2002;325(7367):740.
40. Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health. 2000;90(10):1595-1600.
41. Weinrich SP, Weinrich M, Ellison G, Hudson J, Reeder G, Weissbecker I. Contrasting cost of a prostate cancer educational program by income. Am J Health Behav. 2000;24(6):422.
42. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. [comment]. N Engl J Med. 2002;347(11):781.
43. Chan EC, Vernon SW, O'Donnell FT, Ahn C, Greisinger A, Aga DW. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health. 2003;93(5):779.
44. Flood AB, Wennberg JE, Nease RF Jr, Fowler FJ Jr, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. [comment]. J Gen Intern Med. 1996;11(6):342.
45. Mainous AG III, Hagen MD. Public awareness of prostate cancer and the prostate-specific antigen test. Cancer Pract. 1994;2(3):217.
46. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA. 2003;289(11):1414.
47. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8(4):333.
48. Abbott RR, Taylor DK, Barber K. A comparison of prostate knowledge of African-American and Caucasian men: changes from prescreening baseline to Postintervention. Cancer J Sci Am. 1998;4:175.
49. Weinrich SP, Reynolds WA Jr, Tingen MS, Starr CR. Barriers to prostate cancer screening. Cancer Nurs. 2000;23(2):117.
50. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999;91(16):1409.